Jan 11, 2022 04:59 PM (GMT+8) · EqualOcean
Financial Associated Press, January 11 - Zhejiang Pharmaceutical announced that recently, the company's subordinate production enterprise Xinchang pharmaceutical factory (hereinafter referred to as "Xinchang pharmaceutical") received the GMP certificate issued by MHRA, which is valid for 3 years, marking that Xinchang pharmaceutical has passed the British GMP certification and meets the requirements of the British drug quality system. The oral solid preparation workshop that passed the MHRA remote compliance inspection was levofloxacin tablets.